Bank of New York Mellon
FURX

Bank of New York Mellon’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bank of New York Mellon’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-37,188
Closed -$3.95M – 4297
2014
Q2 		$3.95M Sell
37,188
-18,487
-33% -$1.81M ﹤0.01% 2460
2014
Q1 		$4.84M Sell
55,675
-32,058
-37% -$2.47M ﹤0.01% 2322
2013
Q4 		$3.69M Buy
87,733
+5,729
+7% +$236K ﹤0.01% 2484
2013
Q3 		$3.61M Buy
82,004
+8,282
+11% +$343K ﹤0.01% 2448
2013
Q2 		$2.51M Buy
+73,722
New +$2.59M ﹤0.01% 2650

Bank of New York Mellon's FURX Position: Q3 2014 in Review

Bank of New York Mellon sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 37,188 shares — an estimated $3.95M sold.

Bank of New York Mellon first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $4.84M in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Bank of New York Mellon reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Bank of New York Mellon sold 37,188 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $3.95M.
  • Bank of New York Mellon first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Bank of New York Mellon's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $4.84M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Bank of New York Mellon's 13F filing for Q3 2014, filed 13 Nov 2014.